Cash Flow Immunovant, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-412.00
-258.00
-210.00
-156.00
-107.00
-66.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-12.00
2.00
-10.00
15.00
4.00
4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-375.00
-214.00
-188.00
-106.00
-83.00
-53.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
454.00
472.00
70.00
200.00
383.00
146.00
Net Cash Inflow / Outflow
78.00
258.00
-117.00
93.00
299.00
93.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Immunovant, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-412.949
-463.927
51.00
10.99%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-12.031
-54.895
42.00
78.08%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-375.874
-452.627
77.00
16.96%
Cash Flow from Investing Activities
-0.759
-2005.666
2,005.00
99.96%
Cash Flow from Financing Activities
454.492
2448.508
-1,994.00
-81.44%
Net Cash Inflow / Outflow
78.606
-9.359
87.00
939.90%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.747
0.426
0.00
75.35%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -75.46% vs -13.83% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-375.87
-214.23
-75.46%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
